Keymed Biosciences, Inc.(HK:2162)
HK$69.85-1.15 (-1.62%)
HK:2162
Keymed Biosciences, Inc. financials statements
HK$69.85
At close:-1.15 (-1.62%)
Want to see HK:2162 full AI Analyst Report?
Keymed Biosciences, Inc. (2162) Income Statement
1 Followers
Keymed Biosciences, Inc. Income Statement
Last quarter (Q2 2026), Keymed Biosciences, Inc.'s total revenue was ¥608.55M, an increase of 1012.89% from the same quarter last year. In Q2, Keymed Biosciences, Inc.'s net income was ¥1.20B. See Keymed Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 697.77M | ¥ 428.12M | ¥ 354.10M | ¥ 100.06M | ¥ 110.27M | |
| ¥ 516.51M | ¥ 415.92M | ¥ 317.22M | ¥ 97.48M | ¥ 93.07M | |
| ¥ 1.10B | ¥ 1.03B | ¥ 752.02M | ¥ 641.29M | ¥ 450.61M | |
| Depreciation and Amortization | ¥ 98.03M | ¥ 93.23M | ¥ 69.16M | ¥ 36.12M | ¥ 21.02M |
| ¥ -486.83M | ¥ -532.86M | ¥ -269.77M | ¥ -259.25M | ¥ -3.86B | |
| ¥ -584.85M | ¥ -618.10M | ¥ -434.80M | ¥ -543.81M | ¥ -3.88B | |
| ¥ 77.61M | ¥ 109.45M | ¥ 78.61M | ¥ 240.21M | ¥ -3.52B | |
| ¥ -507.25M | ¥ -508.65M | ¥ -356.19M | ¥ -303.60M | ¥ -3.89B | |
| ¥ -509.11M | ¥ -515.24M | ¥ -359.36M | ¥ -308.12M | ¥ -3.90B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -1.86 | ¥ -1.97 | ¥ -1.37 | ¥ -1.18 | ¥ -24.24 |
| Diluted EPS | ¥ -1.86 | ¥ -1.97 | ¥ -1.37 | ¥ -1.18 | ¥ -24.24 |
| Weighted Average Shares Outstanding | 273.98M | 261.95M | 261.37M | 261.13M | 160.85M |
| Weighted Average Shares Outstanding (Diluted) | 273.98M | 261.95M | 261.37M | 261.13M | 160.85M |
Currency in CNY
